Alaunos Therapeutics, Inc. short interest in 2023
In 2023, Alaunos Therapeutics, Inc.'s disclosed short interest ran from 11.19% of shares outstanding on 13 Jan 2023 to 11.23% on 29 Dec 2023, a change of +0.04 percentage points. The year's high was 11.23% on 29 Dec 2023 and its low 9.30% on 15 Nov 2023, averaging 10.25% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 74.88 days on 14 Jul 2023. Full history: Alaunos Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 11.19% (13 Jan 2023)
- End of year
- 11.23% (29 Dec 2023)
- Change
- +0.04 pp
- High
- 11.23% (29 Dec 2023)
- Low
- 9.30% (15 Nov 2023)
- Average
- 10.25%
- Highest days to cover
- 74.88 (14 Jul 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 11.19% | 17.24 | |
| 31 Jan 2023 | 11.14% | 38.22 | |
| 15 Feb 2023 | 10.89% | 36.26 | |
| 28 Feb 2023 | 10.90% | 34.25 | |
| 15 Mar 2023 | 9.60% | 24.20 | 10-K filed, results (8-K) |
| 31 Mar 2023 | 9.77% | 32.55 | |
| 14 Apr 2023 | 9.88% | 60.42 | |
| 28 Apr 2023 | 9.92% | 46.49 | |
| 15 May 2023 | 9.90% | 49.20 | 10-Q filed, results (8-K) |
| 31 May 2023 | 10.37% | 32.64 | |
| 15 Jun 2023 | 10.63% | 50.51 | |
| 30 Jun 2023 | 10.74% | 41.66 | |
| 14 Jul 2023 | 10.73% | 74.88 | |
| 31 Jul 2023 | 10.86% | 62.04 | |
| 15 Aug 2023 | 10.68% | 10.45 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 10.09% | 4.32 | |
| 15 Sep 2023 | 9.82% | 17.79 | |
| 29 Sep 2023 | 9.62% | 15.43 | |
| 13 Oct 2023 | 9.63% | 14.04 | |
| 31 Oct 2023 | 9.99% | 5.87 | |
| 15 Nov 2023 | 9.30% | 4.15 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 9.84% | 5.07 | |
| 15 Dec 2023 | 9.35% | 6.54 | |
| 29 Dec 2023 | 11.23% | 2.05 |
See also: Alaunos Therapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.